Optima Capital
GILD icon

Optima Capital’s Gilead Sciences GILD Stock Holding History

Optima Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$233K Sell
1,565
-143
-8% -$20.1K 0.09% 147
2026
Q2 		$216K Buy
1,708
+13
+0.8% +$1.71K 0.09% 152
2026
Q1 		$236K Buy
1,695
+18
+1% +$2.52K 0.11% 147
2025
Q4 		$206K Sell
1,677
-239
-12% -$29K 0.09% 155
2025
Q3 		$213K Buy
1,916
+24
+1% +$2.73K 0.1% 151
2025
Q2 		$210K Buy
1,892
+18
+1% +$1.92K 0.11% 149
2025
Q1 		$210K Buy
+1,874
New +$193K 0.13% 134

Other funds holding GILD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Optima Capital's GILD Position: Q3 2026 in Review

Optima Capital reduced its Gilead Sciences (GILD) stake by 8.4% in Q3 2026, selling an estimated $20.1K and leaving 1,565 shares worth $233K. The position accounts for 0.09% of the portfolio, ranked #147.

Optima Capital first reported a position in GILD in Q1 2025 and has held it in 7 quarters since. The position peaked at $236K in Q1 2026. 1,582 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Optima Capital held 1,565 shares of Gilead Sciences worth $233K as of Q3 2026.
  • Optima Capital sold 143 Gilead Sciences shares in Q3 2026, an estimated $20.1K.
  • Gilead Sciences made up 0.09% of Optima Capital's portfolio in Q3 2026, its #147 holding.
  • Optima Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 7 quarters since.
  • Optima Capital's Gilead Sciences position peaked at $236K in Q1 2026.
  • 1,582 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Optima Capital's 13F filing for Q3 2026, filed 29 Oct 2026.